Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY MHLW Eyes Extra Budget for Pharma Innovation, Generic Rejig
November 11, 2024
-
BUSINESS Eisai Cuts Leqembi Sales Target as It Sees “Some Delays” in US Uptake
November 11, 2024
-
ACADEMIA Private-Academia Collab Yields 8 Pediatric Drug Approvals in Japan
November 8, 2024
-
REGULATORY Chuikyo Supports Full Rollout of Company Indices for Generics Manufacturers
November 7, 2024
-
BUSINESS Nxera Pharma Eyes 50 Billion Yen in Global Revenue by 2030: CEO
November 7, 2024
-
ACADEMIA Alzheimer’s-Related Guidelines Being Revised to Accommodate Kisunla, Rexulti
November 6, 2024
-
ACADEMIA Japan Crafting Registry of All Hemophilia Patients, Company Use Eyed Too
November 5, 2024
-
REGULATORY Advisory Panel Backs Transfer of GMP Inspection Authority for New Generics to PMDA
November 5, 2024
-
REGULATORY PMDA Opens US Office in Washington, D.C.
November 5, 2024
-
BUSINESS FDA Rolling Submission for Leqembi SC Completed: Eisai
November 5, 2024
-
BUSINESS Kyowa Kirin Picks Abdul Mullick as New President and COO
November 1, 2024
-
BUSINESS Otsuka Holdings Names Makoto Inoue as New CEO
November 1, 2024
-
REGULATORY BeiGene’s Brukinsa, J&J’s Balversa and More Now in Line for Japan Approval
October 31, 2024
-
BUSINESS 604 Employees Raise Hands for Sumitomo’s Buyout Program
October 31, 2024
-
ACADEMIA 50% of Quit-Smoking Clinics Closed or Suspended, Will Champix Re-Supply Bring Them Back Online?
October 30, 2024
-
REGULATORY Ruling Bloc’s Loss of Lower House Majority Might Sway Off-Year Revision Debates
October 29, 2024
-
REGULATORY LDP Loses Big in Snap Election, Many Health-Savvy Members Ousted
October 28, 2024
-
BUSINESS AbbVie Taps Tiago Campos Rodrigues as Japan President
October 28, 2024
-
BUSINESS Recordati to Enter Japan’s Hematology/Oncology Market with Enjaymo Acquisition
October 25, 2024
-
BUSINESS NHI-Market Price Gap Expected to Contract in 2024, Will It Enter Lower 5% Territory?
October 24, 2024
ページ
As Japan approaches the Fiscal System Council’s “autumn recommendation,” a notable shift is taking shape. The Ministry of Finance (MOF),…
Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…